Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma
OBJECTIVES: Gemcitabine and cisplatin (GC) is an active combination in the treatment of metastatic bladder cancer. We have prospectively analyzed the efficacy and tolerability of GC as neoadjuvant treatment of invasive bladder cancer MATERIALS AND METHODS: In this single-institution phase II trial,...
Main Authors: | Daniel Herchenhorn, Rodrigo Dienstmann, Fabio A. Peixoto, Franz S. de Campos, Valdelice O. Santos, Denise M. Moreira, Hedilene Cardoso, Isabele A. Small, Carlos G. Ferreira |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2007-10-01
|
Series: | International Brazilian Journal of Urology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382007000500004 |
Similar Items
-
Comparison of Oncologic Outcomes of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (ddMVAC) with Gemcitabine and Cisplatin (GC) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis
by: Doo Yong Chung, et al.
Published: (2021-06-01) -
Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01) -
Clinical Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy on Muscle-invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2019-04-01) -
Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma
by: Daniel Herchenhorn, et al.
Published: (2007-12-01) -
Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer
by: Marco Massafra, et al.
Published: (2021-01-01)